期刊文献+

纳米缓释载体的研究进展 被引量:2

下载PDF
导出
摘要 作者主要就纳米载体的概念、种类、合成、制备方法和传递效率等方面作简单介绍,并提出了其目前存在的问题及应用展望。
出处 《中国畜牧兽医》 CAS 2007年第5期146-148,共3页 China Animal Husbandry & Veterinary Medicine
  • 相关文献

参考文献14

  • 1朱诗国,吕红斌,向娟娟,唐珂,张必成,周鸣,谭琛,李桂源.一种新型的非病毒DNA传递载体:多聚赖氨酸-硅纳米颗粒[J].科学通报,2002,47(3):193-197. 被引量:21
  • 2张惠宏,胡富强,袁弘,方明.溶剂扩散法制备丙酸倍氯米松固体脂质纳米粒[J].药学学报,2003,38(4):302-306. 被引量:10
  • 3杨时成,朱家壁,梁秉文,杨昌正.喜树碱固体脂质纳米粒的研究[J].药学学报,1999,34(2):146-150. 被引量:91
  • 4常津,刘海峰,许晓秋,原续波,姚康德,尤永平,蒲佩玉.一种新型纳米基因载体的制备及体外实验[J].中国生物医学工程学报,2002,21(6):515-519. 被引量:25
  • 5Bittner B,Mader K,Kroll C.Tetracycline—HC L-loaded poly(DL-lactide-co—glycolide)microspheres prepared by a spray drying technique:influence of gamma2irradiation on radical formation and polymer degradation.J Cont Rolled Release,1999,59(1):23~27.
  • 6Chen Y,Xue Z,Zheng D,et al.Sodium chlorde modified silica nanoparticles as a non—viral vector with a high efficiency of DNA tranfer into cellse[J].Curr Gene Ther,2003,3(3):273~279.
  • 7Davi S S.Biomedical application of nanotechnology implications for drug targering and gene therapy[J].Trends in Biotech,1997,15(2):217~224.
  • 8Haenster J,Szoka F C J.Polyam id oam ine cascade polymers med iate eficienet transfection of cells in culture[J].Bioconjug Chem,1993,4:372~379.
  • 9Kataoka K,Matsumoto T,Yokoyama M,et al.Doxorbicin-loaded poly{ethylene glycol}-poly(β—benzyl—L-aspartate)copolymer mieelles:their pharmaceutical characteristics and biological significance[J].J Control Rel,2000,64(1~3):143.
  • 10Kneuer C,Sameti M,Haltmer E G,et al.Sitica nanoparticles modified with am inosilanes as carriers for plasm id DnA[J].In J Pharm,2000,196(2):257~261.

二级参考文献24

  • 1常津.具有复合靶向抗癌功能的纳米高分子材料[J].中国生物医学工程学报,1996,15(2):97-101. 被引量:44
  • 2常津.纳米高分子材料在抗癌药物控释方面的应用[J].中国生物医学工程学报,1996,15(2):102-106. 被引量:10
  • 3Pierre Lehn, Sylvie Fabrega, Noufissa Oudrhiri, et al. Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors[J]. Adv. Drug Delve. Rev,1998,30:5-11.
  • 4Truong Le, Walsh, Scott M, et al. Gene transfer by DNA-gelatin nanospheres[J]. Arch Biochem Biophys, 1999,361(1):47-56.
  • 5Colin W. Pouton, Leonard W. Seymour. Key issues in non-viral gene delivery[J]. Adv Drug Delve. Rev,1998,34(1):3-19.
  • 6Cristiano, Richard J. Targeted, non-viral gene delivery for cancer gene therapy[J]. Front. Biosci, 1998,3:D1161-D1170.
  • 7Müller RH, Mder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art [J]. Eur J Pharm Biopharm, 2000,50(1):161-177.
  • 8Yang SC, Zhu JB, Lu Y, et al. Body distribution of camptothecin solid lipid nanoparticles after oral administration [J]. Pharm Res, 1999,16(5):751-757.
  • 9Yang SC, Lu LF, Cai Y, et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain [J]. J Controlled Release, 1999,59(3):299-307.
  • 10Müller RH, Maaen S, Weyhers H, et al. Cytotoxicity of magnetite loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles (SLN) [J]. Int J Pharm, 1996,138(1):85-94.

共引文献139

同被引文献36

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部